Asia-Pacific Injectable Drug Delivery Market - Industry Trends and Forecast to 2029

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Asia-Pacific Injectable Drug Delivery Market - Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Reports
  • Dec 2021
  • Asia-Pacific
  • 350 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

Asia Pacific Injectable Drug Delivery Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2023 –2029
Diagramm Marktgröße (Basisjahr)
MILLIONEN USD
Diagramm Marktgröße (Prognosejahr)
MILLIONEN USD
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • Pfizer
  • Teva Pharmaceutical Industries
  • Baxter BD
  • SCHOTT AG
  • Gerresheimer AG

Asia-Pacific Injectable Drug Delivery Market, By Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), Formulation Packaging (Ampoules, Vials, Cartridges, Bottles), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Cancer, Others),  Usage Pattern (Curative Care, Immunization, Other), Site Of Administration (Skin, Circulatory/Musculoskeletal System, Organs, Central Nervous System), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (Japan, China, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2029

Asia-Pacific Injectable Drug Delivery Market Market Analysis and Insights : Asia-Pacific Injectable Drug Delivery Market

Asia-Pacific injectable drug delivery market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 11.45% in the above mentioned forecast period and is expected to reach the USD 297.31 billion by 2029.

Formulations, technologies, procedures and systems for conveying a pharmaceutical ingredient in the body are collectively referred to as drug delivery. Needle-free injectors, pen injectors, auto injectors, and traditional syringes are among the injectable drug delivery systems.

One of the major factors likely to accelerate the growth and demand of the injectable drug delivery industry is the spike in sales for self-injection devices. Furthermore, the worldwide market is growing due to an increase in the incidence of chronic diseases such as diabetes and cancer. The growing need for drug delivery methods, rising healthcare expenditure and increase in research and development activities are the major factors influencing the market growth rate. The growing demand for injectables in treating large variety of disorders including Wilson's disease, autoimmune diseases, haemophilia, hepatitis C, and cystic fibrosis will further boost the market's growth.

Moreover, the high demand for biosimilar and generic injectable, quick scientific innovations and new product releases, and strong growth in the biologics industry will provide beneficial opportunities for the Injectable drug delivery market in the forecast period of 2022-2029.

However, the different infections connected with needle stick injuries and product recalls, are the factors that will hinder the market growth. The rise in demand for other forms of drug delivery will further challenge the Injectable drug delivery market in the forecast period mentioned above.

This Asia-Pacific injectable drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific injectable drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacific Injectable Drug Delivery Market Scope and Market Size

The Asia-Pacific injectable drug delivery market is segmented on the basis of type, formulation packaging, therapeutic application, usage pattern, site of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of type, the injectable drug delivery market is segmented into injectable drug delivery devices and injectable drug delivery formulation. Injectable drug delivery devices have further been segmented into conventional injection devices and self-injection devices. Self-injection devices have further been sub-segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors and others. Injectable drug delivery formulation has further been segmented into conventional drug delivery formulation, novel drug delivery formulation and long-acting injection formulations. Novel drug delivery formulation has further been sub-segmented into colloidal dispersions and microparticles. Colloidal dispersions are further divided into niosomes, liposomes, polymeric/mixed micelles and nanoparticles. Micro particles are further divided into microspheres and microcapsules.
  • On the basis of formulation packaging, the injectable drug delivery market is segmented into ampoules, vials, cartridges and bottles.
  • Based on therapeutic application, the injectable drug delivery market is segmented into autoimmune diseases, hormonal disorders, orphan diseases, cancer and others.
  • On the basis of usage pattern, the injectable drug delivery market is segmented into curative care, immunization and others.
  • Based on site of administration, the injectable drug delivery market is segmented into skin, circulatory/musculoskeletal system, organs and central nervous system.
  • On the basis of end-users, the injectable drug delivery market is segmented into clinic, hospital and others.
  • The injectable drug delivery market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Asia-Pacific Injectable Drug Delivery Market Country Level Analysis

Asia-Pacific injectable drug delivery market is analyzed and market size information is provided by the country, type, formulation packaging, therapeutic application, usage pattern, site of administration, end-users and distribution channel as referenced above.

The countries covered in the Asia-Pacific injectable drug delivery market report are the Japan, China, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines, Rest of Asia-Pacific.

China dominates the Asia-Pacific injectable drug delivery market due to the rising population, changing lifestyle and upsurge in the adoption rate of developed technologies.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Asia-Pacific injectable drug delivery market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Asia-Pacific Injectable Drug Delivery Market Share Analysis

Asia-Pacific injectable drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Asia-Pacific injectable drug delivery market research.

Some of the major players operating in the Asia-Pacific injectable drug delivery market are Pfizer Inc., Teva Pharmaceutical Industries Ltd., Baxter, BD, SCHOTT AG, Gerresheimer AG, Alkermes, Eli Lilly and Company, Sandoz, Terumo Corporation, Ypsomed AG and Bespak Europe Ltd., among others.


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

Asia-Pacific Injectable Drug Delivery Market soars at a CAGR of 11.45% by 2029
Asia-Pacific Injectable Drug Delivery Market will be worth $297.31 billion by 2029
Asia-Pacific Injectable Drug Delivery Market covers Japan, China, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines, Rest of Asia-Pacific.
Asia-Pacific Injectable Drug Delivery Market Key Players are Pfizer Inc., Teva Pharmaceutical Industries Ltd., Baxter, BD, SCHOTT AG, Gerresheimer AG, Alkermes, Eli Lilly and Company, Sandoz, Terumo Corporation, Ypsomed AG and Bespak Europe Ltd.,